LSAK 241220 10.00C (LSAK241220C10000) Stock Options, News & Quotes

0.00
0.000.00%

15min DelayClose Dec 20 09:30 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Trytosaveabit

Nov 19 15:06

Update

$Lesaka Technologies (LSAK.US)$ Reuters· just
Lesaka to Acquire Prepaid Electricity Submetering and Payments Business Recharger, Expanding Alternative Payments Offering! Deal valued at 28 million

Jaguar8

Oct 2 07:06

NEWS

$Lesaka Technologies (LSAK.US)$
Lesaka completes the acquisition of Adumo, cementing its position as the leading independent fintech in Southern Africa
JOHANNESBURG, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. ("Lesaka" or the "Company") (NASDAQ:LSAK, JSE: LSK))) today announced it has completed its acquisition of Adumo RF (Pty) Ltd ("Adumo"). The transaction was settled through the issuance of 17,279,803 shares of Lesaka's common stock and a cash payment ZAR 232.2 million ($...

Jaguar8

Sep 11 15:07

NEWS

$Lesaka Technologies (LSAK.US)$
Lesaka achieves its profitability guidance for FY 2024 and provides significantly higher profitability guidance for FY 2025
Lesaka Technologies (Nasdaq: LSAK; JSE: LSK) reported its FY 2024 results, achieving profitability guidance and providing higher guidance for FY 2025. Key highlights include:
- Revenue increased 11% to $564.2 million (ZAR 10.6 billion)
- Operating income improved to $3.6 million from a loss of $15.3 million in FY 2023
- Net loss improved 4...

GAME_DAY

Sep 19, 2022 21:10

9/20 Watchlist

follow for nightly watchlist ⭐️
latest signal BCAN 5.21 ah
$Femto Technologies (BCAN.US)$ $bluebird bio (BLUE.US)$ $FedEx (FDX.US)$ $Home Depot (HD.US)$ $MicroCloud Hologram (HOLO.US)$ $Lesaka Technologies (LSAK.US)$ $Mobile Global eSports (MGAM.US)$ $NVIDIA (NVDA.US)$ $Vale SA (VALE.US)$ $Veru Inc (VERU.US)$ $Virios Therapeutics (VIRI.US)$